![](/img/cover-not-exists.png)
Tu1818 – Ultra-Proactive Therapeutic Drug Monitoring Incorporating Infliximab Point-Of-Care Testing with Ad Hoc Dose Adjustment Reduces C-Reactive Protein Levels in Patients with IBD During Infliximab Maintenance Treatment
Bossuyt, Peter, Hoefkens, Eveline, Geerts, Inge, Verbiest, Freija, Vermeulen, Edith, Van Olmen, August, Pouillon, LievenVolume:
156
Language:
english
Journal:
Gastroenterology
DOI:
10.1016/s0016-5085(19)39804-x
Date:
May, 2019
File:
PDF, 307 KB
english, 2019